Article Detail - JE Part B
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R5 - Effective January 01, 2023
This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: January 01, 2023
Summary of Article Changes: Under CPT/HCPCS Codes Group 1: Codes added 81451 and the description was revised for 81450. This revision is due to the 2023 Annual/Q1 CPT/HCPCS Code Update and is effective for dates of service on or after 01/01/2023.
Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.
Last Updated Mon, 27 Feb 2023 17:13:58 +0000